Gene · 11331
Papers2,922
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,922
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Prenatal Identification of a Novel Mutation in the MCPH1 Gene Associated with Autosomal Recessive Primary Microcephaly (MCPH) Using Next Generation Sequencing (NGS): A Case Report and Review of the Literature. | Children (Basel) | 2022 | 36553323 | PubTator, text mining | PubMed |
| Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. | Front Mol Biosci | 2022 | 36533073 | PubTator, text mining | PubMed |
| A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma. | Front Oncol | 2022 | 36531021 | PubTator, text mining | PubMed |
| Effect of Lactobacillus Fermentum as a Probiotic Agent on Bone Health in Postmenopausal Women. | J Bone Metab | 2022 | 36529865 | PubTator, text mining | PubMed |
| Formononetin Inhibits Hepatic I/R-Induced Injury through Regulating PHB2/PINK1/Parkin Pathway. | Oxid Med Cell Longev | 2022 | 36506934 | PubTator, text mining | PubMed |
| Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies. | Front Immunol | 2022 | 36505409 | PubTator, text mining | PubMed |
| Diversity of mitophagy pathways at a glance. | J Cell Sci | 2022 | 36504076 | PubTator, text mining | PubMed |
| Exposure to Nanoplastic Particles Enhances Acinetobacter Survival, Biofilm Formation, and Serum Resistance. | Nanomaterials (Basel) | 2022 | 36500844 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer. | JAMA Netw Open | 2022 | 36484990 | PubTator, text mining | PubMed |
| Case Report: Everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia. | Front Pediatr | 2022 | 36483469 | PubTator, text mining | PubMed |
| The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36467404 | PubTator, text mining | PubMed |
| Targeting pancreatic beta cell death in type 2 diabetes by polyphenols. | Front Endocrinol (Lausanne) | 2022 | 36465657 | PubTator, text mining | PubMed |
| Non-classical ferroptosis inhibition by a small molecule targeting PHB2. | Nat Commun | 2022 | 36463308 | PubTator, text mining | PubMed |
| Autoantibodies as biomarkers for breast cancer diagnosis and prognosis. | Front Immunol | 2022 | 36451832 | PubTator, text mining | PubMed |
| Left atrial strain determinants and clinical features according to the heart failure stages. New insight from EACVI MASCOT registry. | Int J Cardiovasc Imaging | 2022 | 36445656 | PubTator, text mining | PubMed |
| A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins. | Front Immunol | 2022 | 36439128 | PubTator, text mining | PubMed |
| Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation. | Cancers (Basel) | 2022 | 36428671 | PubTator, text mining | PubMed |
| Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction. | Biomedicines | 2022 | 36428511 | PubTator, text mining | PubMed |
| High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer. | Technol Cancer Res Treat | 2022 | 36426547 | PubTator, text mining | PubMed |
| Vaccination Strategies Based on Bacterial Self-Assembling Proteins as Antigen Delivery Nanoscaffolds. | Vaccines (Basel) | 2022 | 36423016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11331/papers?page=27